Patent Assignment
Reel/Frame 074186/0531
Assignment of Assignor's Interest
Recorded: 2026-03-25
Pages: 13
Assignor
ZEVRA THERAPEUTICS, INC.
Executed: 2026-03-13
Assignee
COMMAVE THERAPEUTICS SA
AVENUE GIUSEPPE-MOTTA 31-37, GENEVA, 1202, SWITZERLAND
Covered Properties
(37)
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
Application:
61/512,658 →
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methlphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
62/983,614 →
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
17/798,491 →
Publication:
US 2023/0117289
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/569,724 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/654,915 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/654,960 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/676,353 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/691,651 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/712,861 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
63/712,865 →
Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Application:
19/088,541 →
Publication:
US 2025/0375436
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
62/519,629 →
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
62/519,627 →
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application:
62/541,695 →
Compositions Comprising Methylphenidateprodrugs, Processes of Making and Using the Same
Application:
62/685,899 →
Compositions Comprising Methylphenidateprodrugs, Processes of Making and Using the Same
Application:
62/695,134 →
Serdexmethylphenidate Conjugates, Compositions and Methods of Use Thereof
Application:
62/729,155 →
Serdexmethylphenidate Conjugates, Compositions and Methods of Use Thereof
Application:
62/731,574 →
Serdexmethylphenidate Conjugates, Compositions and Methods of Use Thereof
Application:
62/744,528 →
Serdexmethylphenidate Conjugates, Compositions and Methods of Use Thereof
Application:
62/768,457 →
Compositions Comprising Serdexmethylphenidate Conjugates and Methods of Use Thereof
Application:
16/433,525 →
Publication:
US 2019/0381017
Serdexmethylphenidate Conjugates, Compositions and Methods of Use Thereof
Application:
16/433,538 →
Publication:
US 2019/0381018
Serdexmethylphenidate Conjugates, Compositions and Methods of Use Thereof
Application:
16/803,714 →
Publication:
US 2020/0237742
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
PCT:
PCT/US2012/048641 ↗
Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
PCT:
PCT/US2017/065482 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 25, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 032755/0674 →
Security Interest
Jun 3, 2014
From: KEMPHARM, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 033079/0927 →
Assignment of Assignor's Interest
Aug 21, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 033580/0775 →
Corrective Assignment to Correct the Doc Date for Guochen Chi and Doc Date for Bindu Bera Previously Recorded on Reel 033580 Frame 0775. Assignor(S) Hereby Confirms the Doc Date Guochen Chi 03/27/2014 and Doc Date for Bindu Bera 03/24/2014.
Aug 28, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 033648/0173 →
Assignment of Assignor's Interest
Oct 22, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 034007/0354 →
Assignment of Assignor's Interest
Jan 20, 2016
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; BERA, SANJIB
To: KEMPHARM, INC.
Reel/Frame 037531/0211 →
Assignment of Assignor's Interest
Nov 14, 2016
From: GUENTHER, SVEN; MICKLE, TRAVIS; CHI, GUOCHEN; BERA, BINDU
To: KEMPHARM, INC.
Reel/Frame 040312/0818 →
Assignment of Assignor's Interest
Feb 14, 2018
From: GUENTHER, SVEN; CHI, GUOCHEN; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 044933/0589 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 040312 Frame: 0818. Assignor(S) Hereby Confirms the Assignment.
Sep 5, 2018
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 047320/0697 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 037531 Frame: 0375. Assignor(S) Hereby Confirms the Assignment.
Sep 5, 2018
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 047021/0469 →
Assignment of Assignor's Interest
Jun 26, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049596/0001 →
Assignment of Assignor's Interest
Jun 26, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049596/0072 →
Assignment of Assignor's Interest
Jun 26, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 049595/0922 →
Assignment of Assignor's Interest
Dec 11, 2019
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 051245/0645 →
Security Interest
Feb 28, 2020
From: KEMPHARM, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 051968/0714 →
Assignment of Assignor's Interest
Sep 23, 2020
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 053863/0377 →
Assignment of Assignor's Interest
Sep 23, 2020
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 053863/0418 →
Assignment of Assignor's Interest
Oct 20, 2020
From: GUENTHER, SVEN; CHI, GUOCHEN; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 054107/0382 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 054919/0909 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 054919/0858 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MICKLE, TRAVIS; GUENTHER, SVEN; CHI, GUOCHEN
To: KEMPHARM, INC.
Reel/Frame 054920/0066 →
Release of Security Interest
Jul 9, 2021
From: DEERFIELD PRIVATE DESIGN FUND III, L.P.
To: KEMPHARM, INC.
Reel/Frame 056803/0133 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 033648 Frame: 0173. Assignor(S) Hereby Confirms the Assignment.
Aug 26, 2021
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 057322/0436 →
Corrective Assignment to Correct the Assignee's Address on the Assignment Document Previously Recorded at Reel: 040312 Frame: 0818. Assignor(S) Hereby Confirms the Assignment .
Oct 19, 2021
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 057848/0159 →
Change of Name
Jul 26, 2023
From: KEMPHARM, INC.
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 064388/0285 →